Jump to content
  • We are now offering Remote Courses

    Equal benefits to our residential courses, without the travel.

    View Courses
  • eLearning Passport

    All our courses. 12 months access. One flat fee.

    More Information
  • Newsletter

    Non-members can signup to keep up to date with RQA news and events.

    Add your details now

MHRA - Building resilience into clinical trial design and conduct during the pandemic

18th November 2020

On 19 March, the MHRA first produced guidance for researchers on managing clinical trials of investigational medicinal products (IMPs) during the pandemic.  This guidance constituted details about a collection of established flexibilities and technologies that are available, but little used, despite their regulatory acceptance.

Read post

Back to Recent News

Share